SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Hapag-Lloyd's $35-per-share cash acquisition offer is driving intense conversation around ZIM Integrated Shipping, with the community actively discussing the deal's complex regulatory approvals, potential for a short squeeze, and the implications for future dividend payouts given the company's strong cash position.

Sperax is redefining financial autonomy through programmable agents that manage capital, optimize yield, and protect against risk, all transparently on-chain. Founded in 2019, Sperax is backed by leading investors including Jump Trading, Polychain Capital, Amber Group. Sperax offers a new standard in automated, user-driven finance.  The SperaxOS ecosystem is powered by USDs and SPA on Arbitrum, BNB Chain, and other EVM networks. Anchored by two native assets: USDs, a gas-free, auto-yield stablecoin backed by on-chain collateral, and SPA, the governance and value-capture token. Sperax builds open-source tools that turn idle capital into self-optimizing portfolios.  SperaxOS is a cross-chain financial operating system where AI-driven smart agents automate everything from yield farming to payroll, and Demeter, a no-code platform for launching liquidity farms. USDs automatically rebases yield to holders, while SPA lets users register agents, earn protocol fees, and vote on upgrades. Battle-tested through multiple market cycles: Sperax offers individuals, DAOs, and fintechs a borderless toolkit for passive income, risk-managed investing, and fully automated treasury operations, all governed on-chain by its community.

Sperax

Sperax (SPA) is trending with a surge in trading volume, fueled by community discussion about its undervalued status and anticipation for the upcoming launch of SperaxOS, a compliant DeFi system featuring an agent-powered yield and USD-pegged stablecoin, which aligns strategically with recent regulatory developments like the GENIUS Act.

Direxion Shares ETF Trust - Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares is seeing a surge in conversation as the community highlights its impressive past performance and strong institutional accumulation, driven by South Korea's short-selling ban and sustained bullishness in its semiconductor sector, spearheaded by giants like Samsung and SK Hynix.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending as the community eagerly anticipates FDA approval for its Galleri multi-cancer early detection test following a recent PMA submission and positive PATHFINDER 2 study results, with strategic partnerships and legislative progress on Medicare reimbursement further fueling excitement about its disruptive, life-saving potential.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending following the UK's MHRA approval of its Kostaive mRNA COVID-19 vaccine, which triggers milestone payments, while community discussion intensifies around a critical legal battle with AbbVie over alleged trade secret theft. Investors are also keenly watching for further data on its Cystic Fibrosis program, with many highlighting early signs of mucus plug reduction as a positive biological signal despite mixed initial lung function results, fueling debate over the stock's significant undervaluation.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamai Technologies is trending following significant analyst upgrades and re-ratings positioning it as a key "AI play" and leader in edge computing, particularly with its NVIDIA partnership. The community is actively discussing expectations for substantial upside and strong quarterly performance, drawing comparisons to recent blockbuster results from competitors like Fastly and Cloudflare.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as its community actively "spreads the virus" narrative, celebrating the milestone of 600 watchers and reinforcing its pure meme culture. Despite broader market dips, conviction remains high, with supporters viewing current levels as a strong entry point for this Solana-based meme coin.

Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.

Bridgford Foods Corp.

Bridgford Foods Corporation

Bridgford Foods (BRID) is trending as the community speculates on potential gross margin boosts from increased beef imports and the company's aggressive expansion into private-label offerings with major retailers, positioning it as an undervalued defensive play.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amid high anticipation for topline data from its SOL-1 Phase 3 superiority trial in wet AMD, scheduled for release and presentation at a prominent scientific conference. Investors are actively discussing the potential for a "superiority label" and persistent buyout speculation, with many expecting positive results to drive a significant re-rating of the stock.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

Community discussion is intensely focused on claims linking Bitcoin to alleged illicit activities and the fallout from recent file releases, fueling a pervasive narrative that Bitcoin is a "scam" or "pedo-currency." This strong bearish sentiment is driving significant interest in $BITI, as many anticipate a market collapse for Bitcoin and seek to capitalize on its potential decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $ABVX  
-- &gt; as well as its required to be an active trial for the FDA to Conditionally Approve 009 for AML-MR Post VEN Failure.   
not sure if everyone Understands this --  
per Fda rules, in order to conditionally approve any new drug - the said drug must be in active Registrational Trial. 
Once the 009 PR hits - we could see the Conditional Accelerated Approval for SLS009 Cohort 4 and 5:  
Safe Effective and Durable for Dying Patients, who&#39;ve Failed All other Treatments 
 
Not Sure what is taking So Long - the Trial was announced in July - the EU AML Impact Program, required all T&#39;s to be Crossed  
-- has to be Something they are awaiting from the FDA.  
thusly - i am B---earish...

Keith Thompson

Tony M

EVANERV

Frog Prince

6,700% ROI this quarter

Connor2184

CMSP

$SLS $ABVX From $5 to $148 - the Power of a Phase 3 PR. 
+ the SLS009 RANDOMIZED Registrational Trial - First patient Dosed PR will be Very Valuable - as well as its required to be an active trial for the FDA to Conditionally Approve 009 for AML-MR Post VEN Failure. 
- 009 4x increase in Survival - the first ever Safe CDK9 Cohort 4 MOS that Was Not YET REACHED - Open Data. 
- hugely valuable 009 PR COMING. 
- But Still Not even Close to Value of the GPS PHASE 3 Results - 5 years in the Making - are Inevitable 
- and we are close to the IMMINENT ZONE - SMART MONEY KNOWS RIGHT NOW, 165 Funds moving in Ahead of Time.

StockTwits Web

SELLAS Life Sciences Group Inc

Abivax - ADR

$SLS Great time to invest while the whole $XBI gets Pounded. 
 
- irrelevant -- short term market manipulation. 
 
- a 009 PR including the correct FDA approval language for this randomized trial could launch this to double digits  
-- and everyone knows the GPS P3 Results worth $40B to Big Pharma are Coming, they are Inevitable.  
 
Investment Opportunity of a Lifetime - VERY BULLISH.

  
-- > as well as its required to be an active trial for the FDA to Conditionally Approve 009 for AML-MR Post VEN Failure.   
not sure if everyone Understands this --  
per Fda rules, in order to conditionally approve any new drug - the said drug must be in active Registrational Trial. 
Once the 009 PR hits - we could see the Conditional Accelerated Approval for SLS009 Cohort 4 and 5:  
Safe Effective and Durable for Dying Patients, who've Failed All other Treatments 
 
Not Sure what is taking So Long - the Trial was announced in July - the EU AML Impact Program, required all T's to be Crossed  
-- has to be Something they are awaiting from the FDA.  
thusly - i am B---earish...